Sridhar Kottakota serves as the Vice President and Head of R&D at Indian Immunologicals Limited, where he leverages his extensive 30 years of global experience in the bio-pharma industry to drive innovation and excellence in vaccine development and biologics. With a profound technical understanding of...
Sridhar Kottakota serves as the Vice President and Head of R&D at Indian Immunologicals Limited, where he leverages his extensive 30 years of global experience in the bio-pharma industry to drive innovation and excellence in vaccine development and biologics. With a profound technical understanding of biologics, including recombinant proteins, biosimilars, and both microbial and viral vaccines, Sridhar has been instrumental in advancing the company's research and development initiatives. His expertise encompasses critical areas such as process development, scale-up, and technology transfer, ensuring that cutting-edge biotechnological advancements are seamlessly integrated into manufacturing processes.
At Indian Immunologicals, Sridhar leads key projects that focus on the development of serum-free and chemically defined media, optimizing cell bank characterization, and enhancing downstream processing techniques. His commitment to process characterization and validation is pivotal in maintaining compliance with GxP standards, thereby ensuring the highest quality in product development. Sridhar's proficiency in molecular biology, fermentation, and protein purification further underscores his capability to navigate the complexities of drug discovery and development in the life sciences sector.
Under his leadership, the R&D division is not only focused on current projects but is also poised to explore new frontiers in vaccine technology and biologics manufacturing. Sridhar's vision is to position Indian Immunologicals as a leader in the industry, fostering innovation that addresses global health challenges while adhering to the highest standards of scientific integrity and operational excellence. His strategic approach and deep-rooted knowledge make him a pivotal figure in the advancement of biopharmaceuticals in India and beyond.
